Twain has a rich and deep patent portfolio covering the initial concepts underpinning its agonistic antibody approach, together with a series of patent families covering the development of the TRON product.
Granted in US and Europe. Also filed in 10 other countries
Filed in US, Europe, China, Japan & Singapore